GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (LTS:0DTR) » Definitions » Long-Term Capital Lease Obligation

Bioton (LTS:0DTR) Long-Term Capital Lease Obligation : zł10.5 Mil (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Bioton Long-Term Capital Lease Obligation?

Bioton's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was zł10.5 Mil.

Bioton's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (zł11.9 Mil) to Dec. 2023 (zł11.0 Mil) and declined from Dec. 2023 (zł11.0 Mil) to Mar. 2024 (zł10.5 Mil).

Bioton's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (zł13.4 Mil) to Dec. 2022 (zł11.8 Mil) and declined from Dec. 2022 (zł11.8 Mil) to Dec. 2023 (zł11.0 Mil).


Bioton Long-Term Capital Lease Obligation Historical Data

The historical data trend for Bioton's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton Long-Term Capital Lease Obligation Chart

Bioton Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.25 6.86 13.41 11.85 10.98

Bioton Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.76 10.80 11.88 10.98 10.52

Bioton  (LTS:0DTR) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Bioton Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Bioton's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioton (LTS:0DTR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (LTS:0DTR) » Definitions » Long-Term Capital Lease Obligation
Traded in Other Exchanges
Address
Ul. Staro?ci?ska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.

Bioton (LTS:0DTR) Headlines

No Headlines